Literature DB >> 9625801

Genetic and epigenetic influences in prostatic carcinogenesis (review).

S W Hayward1, G D Grossfeld, T D Tlsty, G R Cunha.   

Abstract

Prostatic carcinogenesis is a multistep process with well-documented stages. Although prostate cancer is a major cause of mortality many small tumor foci never progress to form clinically significant disease, indicating that the disease process may be regulated at more than one level. Carcinogenesis is accompanied by increasing genetic damage to prostatic epithelial cells, however the pattern of genetic lesions is inconsistent. The differentiation of stromal cells surrounding tumors is more fibroblastic and less muscular than in normal prostate. The present communication reviews the roles of both genetic and, stromally derived, epigenetic effects on prostatic tumorigenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9625801

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Genomewide scan for prostate cancer-aggressiveness loci.

Authors:  J S Witte; K A Goddard; D V Conti; R C Elston; J Lin; B K Suarez; K W Broman; J K Burmester; J L Weber; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-05-24       Impact factor: 11.025

2.  Role of stromal-epithelial interaction in the formation and development of cancer cells.

Authors:  Viktor Shtilbans
Journal:  Cancer Microenviron       Date:  2013-02-22

Review 3.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.

Authors:  G A Gmyrek; M Walburg; C P Webb; H M Yu; X You; E D Vaughan; G F Vande Woude; B S Knudsen
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile.

Authors:  Alvin Y Liu; Martine P Roudier; Lawrence D True
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 6.  Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

7.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.

Authors:  Lawrence D True; Hui Zhang; Mingliang Ye; Chung-Ying Huang; Peter S Nelson; Priska D von Haller; Larry W Tjoelker; Jong-Seo Kim; Wei-Jun Qian; Richard D Smith; William J Ellis; Emily S Liebeskind; Alvin Y Liu
Journal:  Mod Pathol       Date:  2010-06-18       Impact factor: 7.842

8.  Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.

Authors:  Jianguo Zhu; Cong Pan; Jun Jiang; Mingsen Deng; Hengjun Gao; Bozhao Men; Michael McClelland; Dan Mercola; Wei-D Zhong; Zhenyu Jia
Journal:  Oncotarget       Date:  2015-06-30

9.  Tumor-associated myeloid cells promote tumorigenesis of non-tumorigenic human and murine prostatic epithelial cell lines.

Authors:  Stephanie N Sass; Kimberley D Ramsey; Shawn M Egan; Jianmin Wang; Eduardo Cortes Gomez; Sandra O Gollnick
Journal:  Cancer Immunol Immunother       Date:  2018-03-03       Impact factor: 6.968

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.